<DOC>
	<DOCNO>NCT01418417</DOCNO>
	<brief_summary>Objective : To compare single dose bioavailability Torrent 's Pantoprazole Sodium Delayed - Release Tablets 1 × 40 mg PROTONIX® ( Pantoprazole Sodium ) Delayed - Release Tablets 1 × 40 mg Wyeth Pharmaceutical Inc. Dosing period separate washout period least 7 day . Study Design : randomize , open label , two treatment , two period , two sequence , single dose , crossover study healthy human adult subject</brief_summary>
	<brief_title>Bioequivalence Study Torrent Pharmaceutical Limited 's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Healthy human adult subject 1855 year age ( inclusive ) , body mass index ( BMI ) 18 27 kg/m2 . Subjects evidence underlie disease screen history whose physical examination perform within 21 day prior commencement study . Subjects whose screen laboratory value within normal limit consider physician/Principal Investigator clinical significance . Informed consent give write form accord section 11.3 protocol . Female Subjects : 1 . Of child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . 2 . Postmenopausal least 1 year . 3 . Surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) . History presence significant : 1 . Cardiovascular , pulmonary , hepatic , renal , hematological , gastrointestinal , endocrine , immunologic , dermatologic , musculoskeletal , neurological psychiatric disease . 2 . Alcohol dependence , alcohol abuse drug abuse within past one year . 3 . Moderate heavy smoking ( &gt; 10 cigarettes/day ) consumption tobacco product . 4 . History difficulty swallow tablet / capsule . 5 . Clinically significant illness within 4 week start study 6 . Asthma , urticaria allergic type reaction take medication . 7 . Positive urine drug screening , HIV , Hepatitis B &amp; C test . 8 . Any history hypersensitivity Pantoprazole Sodium . 9 . Existence surgical medical condition , , judgment clinical investigator might interfere pharmacokinetics drug likely compromise safety subject . 10 . Inability communicate cooperate investigator due language problem , attitude , poor mental development / impair cerebral function . Subject participate clinical trial involve drug administration collection blood sample donate blood precede 12 week prior start study . Subjects : 1 . Systolic blood pressure le 90 mm Hg 150 mm Hg . 2 . Diastolic blood pressure le 60 mm Hg 94 mm Hg . 3 ) Minor deviation ( 24 mm Hg ) checkin may acceptable discretion physician /investigator . 4 ) Pulse rate 50/minute 105/minute .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>